Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide in Acute Diastolic Heart Failure
NCT00083772Phase 4Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2004
- Primary completion
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of nesiritide in heart failure with preserved ejection fraction (HFpEF), sponsored by University of Texas MD Anderson Cancer Center. Started May 2004; status: terminated.
02
Drugs
nesiritide
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT00083772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083772.